amyloid aggregation
Recently Published Documents


TOTAL DOCUMENTS

629
(FIVE YEARS 200)

H-INDEX

52
(FIVE YEARS 11)

2022 ◽  
Vol 23 (2) ◽  
pp. 783
Author(s):  
Diana Fedunova ◽  
Andrea Antosova ◽  
Jozef Marek ◽  
Vladimir Vanik ◽  
Erna Demjen ◽  
...  

Amyloid fibrils draw attention as potential novel biomaterials due to their high stability, strength, elasticity or resistance against degradation. Therefore, the controlled and fast fibrillization process is of great interest, which raises the demand for effective tools capable of regulating amyloid fibrillization. Ionic liquids (ILs) were identified as effective modulators of amyloid aggregation. The present work is focused on the study of the effect of 1-ethyl-3-methyl imidazolium-based ILs with kosmotropic anion acetate (EMIM-ac) and chaotropic cation tetrafluoroborate (EMIM-BF4) on the kinetics of lysozyme amyloid aggregation and morphology of formed fibrils using fluorescence and CD spectroscopy, differential scanning calorimetry, AFM with statistical image analysis and docking calculations. We have found that both ILs decrease the thermal stability of lysozyme and significantly accelerate amyloid fibrillization in a dose-dependent manner at concentrations of 0.5%, 1% and 5% (v/v) in conditions and time-frames when no fibrils are formed in ILs-free solvent. The effect of EMIM-BF4 is more prominent than EMIM-ac due to the different specific interactions of the anionic part with the protein surface. Although both ILs induced formation of amyloid fibrils with typical needle-like morphology, a higher variability of fibril morphology consisting of a different number of intertwining protofilaments was identified for EMIM-BF4.


2022 ◽  
Author(s):  
Habbanakuppe D. Preetham ◽  
Umashankara Muddegowda ◽  
Kothanahally S. Sharath Kumar ◽  
Shobith Rangappa ◽  
Kanchugarakoppal S. Rangappa

Molecules ◽  
2021 ◽  
Vol 27 (1) ◽  
pp. 88
Author(s):  
Marco Giampà ◽  
María J. Amundarain ◽  
Maria Georgina Herrera ◽  
Nicolò Tonali ◽  
Veronica I. Dodero

The aggregation of proteins into amyloid fibers is linked to more than forty still incurable cellular and neurodegenerative diseases such as Parkinson’s disease (PD), multiple system atrophy, Alzheimer’s disease and type 2 diabetes, among others. The process of amyloid formation is a main feature of cell degeneration and disease pathogenesis. Despite being methodologically challenging, a complete understanding of the molecular mechanism of aggregation, especially in the early stages, is essential to find new biological targets for innovative therapies. Here, we reviewed selected examples on α-syn showing how complementary approaches, which employ different biophysical techniques and models, can better deal with a comprehensive study of amyloid aggregation. In addition to the monomer aggregation and conformational transition hypothesis, we reported new emerging theories regarding the self-aggregation of α-syn, such as the alpha-helix rich tetramer hypothesis, whose destabilization induce monomer aggregation; and the liquid-liquid phase separation hypothesis, which considers a phase separation of α-syn into liquid droplets as a primary event towards the evolution to aggregates. The final aim of this review is to show how multimodal methodologies provide a complete portrait of α-syn oligomerization and can be successfully extended to other protein aggregation diseases.


2021 ◽  
Vol 13 ◽  
Author(s):  
Peter Kramer

Alzheimer’s and Parkinson’s are the two best-known neurodegenerative diseases. Each is associated with the excessive aggregation in the brain and elsewhere of its own characteristic amyloid proteins. Yet the two afflictions have much in common and often the same amyloids play a role in both. These amyloids need not be toxic and can help regulate bile secretion, synaptic plasticity, and immune defense. Moreover, when they do form toxic aggregates, amyloids typically harm not just patients but their pathogens too. A major port of entry for pathogens is the gut. Keeping the gut’s microbe community (microbiota) healthy and under control requires that our cells’ main energy producers (mitochondria) support the gut-blood barrier and immune system. As we age, these mitochondria eventually succumb to the corrosive byproducts they themselves release, our defenses break down, pathogens or their toxins break through, and the side effects of inflammation and amyloid aggregation become problematic. Although it gets most of the attention, local amyloid aggregation in the brain merely points to a bigger problem: the systemic breakdown of the entire human superorganism, exemplified by an interaction turning bad between mitochondria and microbiota.


2021 ◽  
Vol 6 (12) ◽  
pp. 4491-4505
Author(s):  
Bibin G. Anand ◽  
Qi Wu ◽  
Govindarajan Karthivashan ◽  
Kiran P. Shejale ◽  
Sara Amidian ◽  
...  

2021 ◽  
pp. 100275
Author(s):  
Álvaro Ruiz-Arias ◽  
Rocío Jurado ◽  
Francisco Fueyo-González ◽  
Rosario Herranz ◽  
Natividad Gálvez ◽  
...  
Keyword(s):  

2021 ◽  
pp. 101469
Author(s):  
Bingkuan Xu ◽  
Shuai Huang ◽  
Yinghui Liu ◽  
Chun Wan ◽  
Yuanyuan Gu ◽  
...  

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Anna Brugulat‐Serrat ◽  
Gonzalo Sánchez‐Benavides ◽  
Raffaele Cacciaglia ◽  
Gemma Salvadó ◽  
Lyduine E. Collij ◽  
...  

Author(s):  
Shani Ben-Zichri ◽  
Ravit Malishev ◽  
Ofek Oren ◽  
Daniel N. Bloch ◽  
Ran Taube ◽  
...  

2021 ◽  
Vol 134 (22) ◽  

ABSTRACT First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Emma Lacroix is first author on ‘Evolutionary conservation of systemic and reversible amyloid aggregation’, published in JCS. Emma is a PhD student in the lab of Dr Tim Audas at Simon Fraser University, Burnaby, Canada, investigating stress-induced physiological amyloid aggregation.


Sign in / Sign up

Export Citation Format

Share Document